CTB
VRTX icon

Country Trust Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Country Trust Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.9M Sell
100,360
-4,715
-4% -$2.09M 0.87% 26
2026
Q1 		$46.9M Buy
105,075
+4,482
+4% +$2.09M 0.89% 27
2025
Q4 		$45.6M Buy
100,593
+2,061
+2% +$888K 0.83% 30
2025
Q3 		$38.6M Buy
98,532
+8,396
+9% +$3.51M 0.84% 36
2025
Q2 		$40.1M Buy
90,136
+312
+0.3% +$144K 0.9% 37
2025
Q1 		$43.5M Buy
89,824
+6,222
+7% +$2.9M 1.1% 28
2024
Q4 		$33.7M Sell
83,602
-10,489
-11% -$4.86M 0.84% 42
2024
Q3 		$43.8M Sell
94,091
-250
-0.3% -$120K 1.07% 30
2024
Q2 		$44.2M Buy
94,341
+16
+0% +$6.95K 1.12% 26
2024
Q1 		$39.4M Sell
94,325
-7,859
-8% -$3.32M 1.02% 32
2023
Q4 		$41.6M Sell
102,184
-17,605
-15% -$6.5M 1.16% 30
2023
Q3 		$41.7M Sell
119,789
-13,477
-10% -$4.71M 1.22% 23
2023
Q2 		$46.9M Sell
133,266
-4,435
-3% -$1.49M 1.27% 24
2023
Q1 		$43.4M Sell
137,701
-9,722
-7% -$2.92M 1.23% 26
2022
Q4 		$42.6M Sell
147,423
-940
-0.6% -$286K 1.26% 27
2022
Q3 		$43M Buy
148,363
+17,752
+14% +$5.11M 1.35% 22
2022
Q2 		$36.8M Sell
130,611
-7,027
-5% -$1.88M 1.16% 31
2022
Q1 		$35.9M Sell
137,638
-42,030
-23% -$9.97M 1% 39
2021
Q4 		$39.5M Buy
179,668
+19,269
+12% +$3.75M 1.07% 32
2021
Q3 		$29.1M Buy
160,399
+65,631
+69% +$12.8M 0.85% 49
2021
Q2 		$19.1M Buy
94,768
+94,588
+52,549% +$19.8M 0.57% 65
2021
Q1 		$39K Hold
180
– – ﹤0.01% 215
2020
Q4 		$43K Buy
+180
New +$41.3K ﹤0.01% 191
2019
Q1 		– Sell
-14
Closed -$2K – 336
2018
Q4 		$2K Buy
14
+6
+75% +$1.04K ﹤0.01% 292
2018
Q3 		$2K Hold
8
– – ﹤0.01% 302
2018
Q2 		$1K Sell
8
-30
-79% -$4.65K ﹤0.01% 300
2018
Q1 		$6K Buy
+38
New +$6.21K ﹤0.01% 244

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Country Trust Bank's VRTX Position: Q2 2026 in Review

Country Trust Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 4.5% in Q2 2026, selling an estimated $2.09M and leaving 100,360 shares worth $49.9M. The position accounts for 0.87% of the portfolio, ranked #26.

Country Trust Bank first reported a position in VRTX in Q1 2018 and has held it in 27 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Country Trust Bank held 100,360 shares of Vertex Pharmaceuticals worth $49.9M as of Q2 2026.
  • Country Trust Bank sold 4,715 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.09M.
  • Vertex Pharmaceuticals made up 0.87% of Country Trust Bank's portfolio in Q2 2026, its #26 holding.
  • Country Trust Bank first reported a position in Vertex Pharmaceuticals in Q1 2018 and has held it in 27 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.